Low-dose Radiotherapy in Indolent Lymphoma:A Multi-center Phase II Study
Low-dose Radiotherapy in Indolent Lymphoma:A Multi-center Phase II Study
The current study is a phase II multi-center single arm trial to evaluate the efficacy and safety of low-dose radiotherapy (3 Gy*4f) in indolent lymphoma.
Inclusion Criteria:
Exclusion Criteria: